• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

adaptive clinical trials

bowel
CRO

GI-focused CRO boosts trial tech with adaptive software

Alimentiv will use the tech in trials on inflammatory bowel disease, celiac disease, eosinophilic gastrointestinal disease and related diseases.
Darren Incorvaia Feb 3, 2025 11:40am
chameleon plants green reptile lizard

Quanticate, PhaseV team up for adaptive trial service

Apr 30, 2024 3:40pm
Illustration of psychotherapy online session or video call

Emmes calls in telehealth capabilities for eClinical platform

Sep 28, 2023 4:30am
ALS spinal cord nervous system brain spine

QurAlis, Unlearn link to use machine learning in ALS research

Jun 28, 2023 11:30am
Machine learning artificial intelligence AI database

Phesi touts new AI platform could save $7M per phase 3 trial

Oct 20, 2022 5:30am
decentralized clinical trials virtual enrollment

VigiLanz rolls out new clinical trial enrollment tool

Oct 13, 2022 9:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings